openPR Logo
Press release

Nasdaq Stocks Soaring to the Top with Strategic Splits: NVDA, INBS, JAGX, SINT, GWAV

06-04-2024 10:42 PM CET | Energy & Environment

Press release from: ABNewswire

Nasdaq Stocks Soaring to the Top with Strategic Splits: NVDA,

Investor interest shifting towards certain companies in the coming days due to recent developments. This article highlights five companies poised to attract attention.

Nvidia Inc (NASDAQ: NVDA) will execute a stock split at the market's close on Friday, June 7, 2024. If you were a shareholder of record holding common stock as of the market's close on Thursday, June 6, you will receive an additional nine shares of NVDA for each share you previously held. This marks the sixth forward stock split in the company's history. Nvidia's strong financials and approaching $3 trillion market cap could surpass Apple Inc. (NASDAQ: AAPL), whose market cap surged after their last stock split.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) experienced significant growth, providing innovative, rapid, non-invasive drug testing solutions to over 400 customers across 15+ industries in the UK. In the nine months ending March 31, 2024, revenue reached approximately $2.38 million, marking a 193% year-over-year increase, with the UK contributing around 93%. High-margin cartridge sales accounted for about 49% of total revenue. Over the 12 months ending March 31, 2024, the company acquired 111 new accounts. The successful adoption in the UK suggests promising potential for Intelligent Bio Solutions in the US, pending its planned FDA 510(k) submission and anticipated product launch in early 2025. The stock price surged to an intraday high 11.70 and a closing high of $6.77 in February 2024 following their stock split on January 29, 2024.

Jaguar Health Inc (NASDAQ: JAGX) after a stock split on May 23, 2024, the company announced on May 29 that it had signed an out-licensing agreement with its joint venture firm Magdalena Biosciences Inc. This joint venture, formed with Filament Health Corp, focuses on developing unique, natural prescription plant-derived medicines for mental health issues. Jaguar Health revealed that the collaboration's scope had expanded to include the development of a prescription botanical drug candidate for treating schizophrenia. The news release highlighted that, according to the agreement, the company would also receive royalties from sales in the United States schizophrenia market, which could reach a valuation of $8.06 billion by 2030.

SINTX Technologies Inc (NASDAQ: SINT), after a stock split on May 23, 2024, this manufacturer and developer of advanced ceramic materials and related technologies, was in the spotlight on May 29 following a significant announcement. SINTX Technologies revealed that it had entered into a 5-year strategic agreement with Myosung Co Ltd. Under this agreement, Myosung would represent SINTX Technologies' interests in Korea, focusing on cultivating clients in the technical ceramic products space. The announcement highlighted that SINTX Technologies offers a significantly differentiated and novel product range in the technical ceramics industry. Myosung decided to support the company's Korean expansion after being suitably impressed during previous collaborations.

Greenwave Technology Solutions Inc (NASDAQ: GWAV), a metal recycling company, announced on May 29 that it would implement a reverse stock split. The reverse stock split, effective on May 31, 2024, would be executed at a 1-for-150 ratio. In the news release, the company stated that this move aimed to boost the trading price per share and meet NASDAQ's minimum bid price requirements to remain listed on the exchange. It was also revealed that the stock would begin trading on a split-adjusted basis starting June 3, 2024.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=nasdaq-stocks-soaring-to-the-top-with-strategic-splits-nvda-inbs-jagx-sint-gwav]
Country: United States
Website: http://www.thestreetreports.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nasdaq Stocks Soaring to the Top with Strategic Splits: NVDA, INBS, JAGX, SINT, GWAV here

News-ID: 3525996 • Views:

More Releases from ABNewswire

Stargardt Disease Market: High-Growth Opportunities for Investors to 2034 - DelveInsight | Ocugen, Kubota Vision Inc, Nanoscope Therapeutics, RBP4 Pty Ltd, Stargazer Pharma, Belite Bio, Alkeus Pharma
Stargardt Disease Market: High-Growth Opportunities for Investors to 2034 - Delv …
The Key Stargardt Disease Companies in the market include - Ocugen, Kubota Vision Inc, Nanoscope Therapeutics Inc., RBP4 Pty Ltd, Stargazer Pharmaceuticals, Inc., Belite Bio, Inc, Alkeus Pharmaceuticals, Inc., IVERIC bio, Inc., Kubota Vision Inc., Astellas Institute, Nanoscope Therapeutics, Alkeus Pharmaceuticals, and others. The Stargardt Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Stargardt Disease pipeline products
Western Rooter & Plumbing in Arcadia, CA Expands Fleet with New Trenchless Sewer Replacement and Repair Truck
Western Rooter & Plumbing in Arcadia, CA Expands Fleet with New Trenchless Sewer …
Western Rooter & Plumbing has added a new trenchless sewer repair and replacement truck to its fleet, expanding its ability to provide faster, less invasive sewer line services across Southern California. Equipped with advanced trenchless technology, the truck allows for sewer repairs with minimal digging, helping protect landscaping and reduce disruption for residential and commercial plumbing customers. Arcadia, CA - Western Rooter & Plumbing [https://westernrooter.com/] has announced the addition of a
Sarcopenia Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Oncocross, Biophytis, MyMD Pharmaceuticals, Novartis, Regeneron Pharma, Merck
Sarcopenia Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial L …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Sarcopenia pipeline constitutes 18+ key companies continuously working towards developing 20+ Sarcopenia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Sarcopenia Pipeline Insight, 2026 [https://www.delveinsight.com/sample-request/sarcopenia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Sarcopenia Market. The Sarcopenia Pipeline report embraces in-depth commercial and clinical
Real Estate Agent in Austin, TX, Adds Mortgage Licensing to Support Buyers Through the Qualification Process
Real Estate Agent in Austin, TX, Adds Mortgage Licensing to Support Buyers Throu …
Austin, TX - In a strategic move to provide more comprehensive service to his clients, Brian C Folsom has recently obtained his mortgage license, positioning himself as a unique resource in the Austin real estate market. This additional credential allows him to guide buyers through both the home search and financing qualification processes, offering an integrated approach that streamlines the journey to homeownership. The decision to pursue mortgage licensing stems from

All 5 Releases


More Releases for NASDAQ

Blasting Off with Space Sector Companies Including: Ascent Solar Technologies: N …
With the Artemis II Manned Moon Mission Set to Launch Could $ASTI be on the Same Rocket Ride Trajectory as $ASTS and $LUNR? Image: https://www.globalnewslines.com/uploads/2026/02/13b5a8ac7a0c22438ac498119e1b3551.jpg $ASTI is Positioned to Serve the $1 Trillion Global Space Economy Projected by 2040 . Ascent Solar Technologies, Inc. (NASDAQ: ASTI) is backed by 40 years of R&D, 15 years of manufacturing experience, numerous awards, and a comprehensive IP and patent portfolio. ASTI is a leading provider of
Peraso (NASDAQ: PRSO) Pushes Back on Mobix Labs (NASDAQ: MOBX) Takeover Bid, Val …
Peraso Inc. (NASDAQ: PRSO), a leading innovator in mmWave wireless solutions, has officially acknowledged receipt of an unsolicited, non-binding acquisition proposal from Mobix Labs, Inc. (NASDAQ: MOBX). The offer proposes a stock-for-stock exchange that values Peraso at approximately $1.20 per share, representing a 20% premium over its 30-day average closing price. However, Peraso is contesting several key points made in Mobix's June 26 press release. Financials Mischaracterized, Says Peraso Peraso rebuffed Mobix's
ZenaTech's (Nasdaq: ZENA) Nasdaq Listing: A Launchpad for Growth and Innovation
On October 1, ZenaTech (Nasdaq: ZENA) made its debut on the Nasdaq, a pivotal milestone for the company specializing in AI-driven drone solutions and enterprise SaaS (software-as-a-service) applications. As businesses increasingly seek innovative ways to streamline operations and boost productivity, ZenaTech stands ready to meet these demands with its advanced AI drone solutions and comprehensive software applications. Under the leadership of CEO Dr. Shaun Passley, ZenaTech aims to leverage its
Investors Alert: EMCORE (NASDAQ: EMKR), AGBA Group (NASDAQ: AGBA), Peraso Inc. ( …
EMCORE Corporation (NASDAQ: EMKR) saw its shares soar today following a major announcement from Mobix Labs (NASDAQ: MOBX). Mobix Labs, a leader in advanced wireless solutions for military and defense, has submitted a proposal to acquire all outstanding shares of EMCORE for $3.80 per share in cash, positioning itself as a key player in the aerospace and defense sectors. This move could provide immediate value to shareholders, making it an
Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO) …
Pre-market trading is heating up as Black Diamond Therapeutics, Inc. (Nasdaq: BDTX) surges on positive Phase 2 data for its cancer treatment BDTX-1535. Peraso Inc. (NASDAQ: PRSO) continues its expansion into the Asian markets and a major military contract. Kaival Brands (NASDAQ: KAVL) saw its stock surge in early trading today on merger announcement. Other stocks to watch include Banzai International Inc. (NASDAQ: BNZI), which saw a 97.51% rally after
Lawsuit filed for Investors who lost money with Alphabet Inc. (NASDAQ: GOOG, NAS …
An investor, who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), filed a lawsuit over alleged violations of Federal Securities Laws by Alphabet Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), have certain options and for certain investors are short and strict deadlines running. Deadline: May 15, 2023. NASDAQ: GOOG, NASDAQ: GOOGL investors should contact the Shareholders